Company-level financial information
ABBOTT LABORATORIES
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 9,566.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 6,524.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 4,116.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 2,171.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 8,558.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 13,402.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 3,836.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 2,207.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 7,261.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 5,723.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 3,556.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 2,202.0 | SEC filingFeb 20, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 9,581.0 | SEC filingFeb 21, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 6,933.0 | SEC filingFeb 21, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 3,309.0 | SEC filingFeb 21, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 1,777.0 | SEC filingFeb 21, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 10,533.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 7,071.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 3,202.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 1,885.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 7,901.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 4,495.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Common-stock cash dividends | 2,560.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 2,177.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 6,136.0 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 3,687.0 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Common-stock cash dividends | 2,270.0 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 1,638.0 | SEC filingFeb 18, 2022 |